ROIVRoivant Sciences Ltd
ROIV
Roivant Sciences Ltd1,995
Mkt Cap
$19.82BVolume
1,745.0052W High
$30.3352W Low
$8.73PE Ratio
-23.71ROIV Fundamentals
Price
$27.70Prev Close
$27.80Open
$27.7150D MA
$25.80Beta
0.92Avg. Volume
7.31MEPS (Annual)
-$0.2371P/B
4.60Rev/Employee
$38,737.33$3,029.76
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) have earned an average rating of "Moderate Buy" from the eleven ratings firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendat...
MarketBeat·2d ago
Sanford C. Bernstein Begins Coverage on Roivant Sciences (NASDAQ:ROIV)
Sanford C. Bernstein initiated coverage on shares of Roivant Sciences in a research note on Friday. They set an "outperform" rating and a $35.00 target price for the company...
MarketBeat·3d ago
Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 200,000 Shares
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of the firm's stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $28.24, for a total value of $5,648,000.00. Following the sale, the chief executive officer directly owned...
MarketBeat·3d ago
Roivant Sciences (NASDAQ:ROIV) CEO Sells 200,000 Shares
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of Roivant Sciences stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $28.24, for a total value of $5,648,000.00. Following the sale, the chief executive...
MarketBeat·3d ago
Melissa Epperly Sells 41,861 Shares of Roivant Sciences (NASDAQ:ROIV) Stock
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) Director Melissa Epperly sold 41,861 shares of the company's stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $28.68, for a total value of $1,200,573.48. Following the transaction, the...
MarketBeat·4d ago
Roivant Sciences (NASDAQ:ROIV) Director Melissa Epperly Sells 41,861 Shares
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) Director Melissa Epperly sold 41,861 shares of the company's stock in a transaction on Monday, March 16th. The stock was sold at an average price of $28.68, for a total transaction of $1,200,573.48. Following the completion of the transaction...
MarketBeat·5d ago
Roivant Sciences Ltd. $ROIV Shares Purchased by HighVista Strategies LLC
HighVista Strategies LLC grew its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 61.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·7d ago
Roivant Sciences Ltd. $ROIV is Foursixthree Capital LP's 7th Largest Position
Foursixthree Capital LP raised its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 4.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·7d ago
Dimensional Fund Advisors LP Has $140.84 Million Stake in Roivant Sciences Ltd. $ROIV
Dimensional Fund Advisors LP raised its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 18.0% in the third quarter, according to its most recent 13F filing with the Securities...
MarketBeat·12d ago
Roivant Sciences (NASDAQ:ROIV) Reaches New 52-Week High - Here's Why
Roivant Sciences (NASDAQ:ROIV) Sets New 52-Week High - Time to Buy...
MarketBeat·13d ago
<
1
2
...
>